LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006218.4:c.331_345del
PIK3CA
· NP_006209.2:p.(Lys111_Arg115del)
· NM_006218.4
GRCh37: chr3:178916942 AAAAGATCCTCAATCG>A
·
GRCh38: chr3:179199154 AAAAGATCCTCAATCG>A
Gene:
PIK3CA
Transcript:
NM_006218.4
Final call
VUS
Variant details
Gene
PIK3CA
Transcript
NM_006218.4
Protein
NP_006209.2:p.(Lys111_Arg115del)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PS2 is not assessed because the required proband, parental, and tissue-comparison data are unavailable; PM6, PP1, and BS4 are not applicable under the VCEP specification.
Final determination:
Because no criteria were applied, ACMG/AMP 2015 Table 5's rule for cases not meeting a pathogenic or benign threshold results in a Variant of Uncertain Significance.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: the VCEP excludes PVS1 for this gene. |
cspec
|
| PS1 | N/A | Not applicable: PS1 requires a missense variant, and this is an in-frame indel. |
generic_acmg_combination_rules
cspec
|
| PS2 | Not assessed | Not assessed: no proband allele fraction, confirmed parental testing, or affected-versus-other-tissue allele-fraction comparison is available for the variant. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PS3 | Not assessed | Not assessed: no exact-variant functional assay result is available; the only paper reports a different PIK3CA K111delK deletion. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
PMID:29533785
|
| PS4 | Not assessed | Not assessed: the variant is absent from gnomAD, but no affected-case phenotype counts or qualifying Table 2A case evidence are available to assign PS4 points. |
cspec
gnomad_v2
gnomad_v4
PMID:29533785
|
| PM1 | Not met | Not met: residues 111-115 fall outside all four approved PIK3CA domains, whose nearest listed interval ends at residue 108. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PM2 | Not assessed | Not assessed: the variant was absent from four gnomAD datasets, but patient ancestry and an ethnically matched cohort were not documented for the VCEP PM2 requirement. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the VCEP states disease-causing variants are heterozygous, so recessive in-trans evidence is outside PM3's use. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PM4 | N/A | Not applicable: the VCEP explicitly excludes PM4 for these genes, including rare in-frame indels that might cause gain of function. |
cspec
|
| PM5 | N/A | Not applicable: PM5 requires a missense variant, and this is an in-frame indel. |
generic_acmg_combination_rules
cspec
|
| PM6 | N/A | Not applicable: the VCEP directs that assumed de novo evidence without confirmed paternity and maternity is addressed through PS2 and not used as PM6. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PP1 | N/A | Not applicable: the VCEP excludes PP1 because these disease-causing variants are germline mosaic, de novo, or mosaic. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PP2 | N/A | Not applicable: PP2 is restricted to missense constraint, whereas c.331_345del is an in-frame deletion rather than a missense variant. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PP3 | N/A | Not applicable: the VCEP excludes PP3 because these PIK3CA variants are gain-of-function and traditional pathogenicity predictors assess loss-of-function mechanisms. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| PP4 | N/A | Not applicable: the VCEP accounts for phenotype specificity under PS4 rather than PP4. |
cspec
|
| PP5 | N/A | Not applicable: this VCEP states that PP5 is not for use. |
cspec
|
| BA1 | Not met | Not met: the variant was absent from gnomAD v2.1, v4.1, and non-cancer subsets, so no allele frequency exceeded the >0.0926% BA1 threshold. |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: the variant was absent from gnomAD v2.1, v4.1, and non-cancer subsets, so no allele frequency exceeded the >0.0185% BS1 threshold. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not met | Not met: gnomAD reported no variant occurrences, and no family observations were available to reach the VCEP minimum of 3 homozygotes or heterozygotes. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no exact-variant benign functional result is available; the reported K111delK assay tested a different PIK3CA deletion. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
PMID:29533785
|
| BS4 | N/A | Not applicable: the VCEP excludes BS4 for de novo, germline mosaic, or post-zygotic mutations. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| BP1 | N/A | Not applicable: the VCEP excludes BP1 for this gene. |
cspec
|
| BP2 | Not assessed | Not assessed: no documented cis/trans observation with a pathogenic PIK3CA variant is available to satisfy the applicable BP2 phase rule. |
cspec
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
| BP3 | N/A | Not applicable: the VCEP states that these genes lack exon regions that are repetitive and without a known function. |
cspec
|
| BP4 | N/A | Not applicable: BP4 covers synonymous, noncanonical intronic, or UTR variants, whereas this is an exon 2 in-frame deletion. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
spliceai
|
| BP5 | Not assessed | Not assessed: no case documents the variant with an alternate molecular basis for disease. |
cspec
|
| BP6 | N/A | Not applicable: this VCEP states that BP6 is not for use. |
cspec
|
| BP7 | N/A | Not applicable: BP7 covers synonymous, noncanonical intronic, or UTR variants, whereas this is an exon 2 in-frame deletion. |
vcep_clingen_brainmalform_acmg_specifications_v1_1
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.